Skip to main content

Bridgette A. Keller

Associate

[email protected]

+1.212.692.6735

Share:

Bridgette applies her experience in health system administration and ethics in health care to her health law practice. Bridgette advises health care providers, ACOs, health plans, PBMs, and laboratories on a variety of regulatory, fraud and abuse, and business planning matters.

With a background in health care operations, Bridgette is able to provide clients with practical insight that includes a focus on the business implications of health care enforcement defense activities, internal investigations, regulatory compliance, and fraud and abuse analyses of proposed new procedures.

Bridgette's work also includes a focus on ethics in health care principles. As a health care ethicist with the Department of Veterans Affairs National Center for Ethics in Health Care (NCEHC), Bridgette provided technical guidance on health care ethics problems to VA stakeholders, VA Central Office staff, and field-based consultants. She also collaborated on the development of an ethics consultation program and educational materials. Prior to her appointment at the NCEHC, Bridgette served as the Outpatient Clinic Coordinator at the Manhattan Campus of the VA New York Harbor Healthcare System and completed the Graduate Health Administration Training Program at the Washington DC VA Medical Center. Her health care management experience includes outpatient clinical operations, customer service, performance improvement, program development and implementation, data analysis, and supervision of staff.

Bridgette is trained in Lean/Six Sigma thinking and as an examiner for the Baldrige Criteria for Performance Excellence.

Education

  • Seton Hall University (JD)
  • Georgetown University (MS)
  • Villanova University (BS)

Involvement

  • Member, American Health Lawyers Association (AHLA)
  • Member, American Bar Association (ABA)
  • Member, American College of Healthcare Executives (ACHE)
  • Member, American Society of Bioethics and Humanities (ASBH)

Recent Insights

News & Press

Viewpoints

Viewpoint
In its favorable Advisory Opinion 18-11, the OIG explains how a managed care organization’s proposed incentive program to pay network providers to increase the amount of Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) services provided to Medicaid beneficiaries would not violate the Anti-Kickback Statute (AKS).  What is interesting about this Advisory Opinion is that the OIG finds that the health plan’s proposed arrangement would be protected by the managed care safe harbor for eligible managed care organizations (ECMOs), and there are not many opinions addressing this safe harbor.
Viewpoint
Medicare Advantage Organizations (MAOs) have been hailing a federal judge’s recent ruling to vacate the 2014 Overpayment Rule. But, how did we get here? And what does it really mean for MAOs?
News alert for all New Jersey health care providers! A new law went into effect yesterday (August 30, 2018) that changes billing requirements for out-of-network services in New Jersey.
In this issue, we provide an overview of 46 recently unsealed qui tam cases and take an in-depth look at four of those cases. Two of the featured cases were filed by patients, a rare but growing category of relators, in one instance using supporting data from the CMS Medicare database. In addition, we discuss health care qui tam litigation trends based on filings in the 12-month period that ended on June 30, 2018, including the government’s intervention rate and the percentage of cases filed by customers, business partners, consultants, patients, and other nontraditional relators.
Earlier this month, CMS proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program with the goal of “modernizing Medicare and restoring the doctor-patient relationship.”

Opioids Have Our Attention

June 21, 2018| Blog

The government is focusing on opioids.  Whether it be program policies, enforcement, or legislation, combating the opioid epidemic continues to be a major focus for government officials.  It is also a major piece of the health care legislation moving in both the House and the Senate.
HHS's Office of Medicare Hearings and Appeals (OMHA) has long faced a backlog in Medicare appeals to Administrative Law Judges (ALJs). In an effort to address this backlog, OMHA established a Settlement Conference Facilitation (SCF) process.
As we highlighted earlier this month, CMS released both the Contract Year 2019 Final Rules for Medicare Advantage and Part D (Final Rules) and the 2019 Call Letter. These documents are not typically released at the same time, so there is a lot of information for Medicare Advantage organizations and Part D plan sponsors to absorb.
Although the options for accelerated FDA pathways have recently expanded, the current political climate has increased scrutiny of expedited approvals. Next week, my colleague Bethany Hills will be moderating a panel discussion in our Boston office about the realities of pursuing an accelerated pathway.
CMS has slowly but surely been providing additional guidance to Medicare Plans (Medicare Advantage and Part D plans) regarding steps they can and should take to address the opioid epidemic as it relates to their beneficiaries. CMS’s most recent guidance to Plans regarding the opioid epidemic was included in the Advance Notice and Call Letter.

News & Press

Mintz is advising a consortium of investors led by TPG Capital and Welsh, Carson, Anderson & Stowe in their acquisition of Kindred Healthcare, Inc. The definitive agreement totals approximately $4.1 billion in cash including the assumption or repayment of net debt.